| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 03/12/2002 | US6355253 Bactericidal antibodies |
| 03/12/2002 | CA2201729C Selective process for the deacylation of acylated compounds |
| 03/12/2002 | CA2189657C Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 03/12/2002 | CA2064077C T cell receptor peptides as therapeutics for autoimmune and malignant disease |
| 03/12/2002 | CA2034741C Therapeutic antibody based fusion proteins |
| 03/07/2002 | WO2002018617A2 Carotenoid production by recombinant, c1-metabolizing methanothropic bacteria |
| 03/07/2002 | WO2001066697A3 Serum free cultivation of primate embryonic stem cells |
| 03/07/2002 | WO2001062948A3 Method and catalyst system for stereoselectively inverting a chiral center of a chemical compound |
| 03/07/2002 | WO2001021772A3 Methods and microorganisms for production of panto-compounds |
| 03/07/2002 | WO2001019870A3 Secreted soluble alpha2delta-2, alpha2delta-3, alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/07/2002 | US20020029393 Pesticidal use of a parasitic flagellate for eliminating or suppressing harmful algae blooms |
| 03/07/2002 | US20020028514 Recombinant AAV vector-based transduction system and use of same |
| 03/07/2002 | US20020028510 Cells for use in the treatment of nervous system disorders |
| 03/07/2002 | US20020028492 Adjusting aliphatic and aromatic hydrocarbon in bacteria; incubate impure sample and bacteria, monitor sample for reduction in hydrocarbon impurities |
| 03/07/2002 | US20020028486 Adjusting affinity of immunoglobulins; generate expression vector, insert preferential sequences, express vector in cells, recover preferential immunoglobulin |
| 03/07/2002 | US20020028448 Evaluating modulators of transcription; obtain modulator, incubate with test protein, monitor modulators binding activity, monitor for adjustment in transcriptional activation and protein expression |
| 03/07/2002 | US20020028436 Suppression of leukocyte transferring in humans; administer immunoglobulins to humans, detect bound receptor, evaluate immune response |
| 03/07/2002 | US20020028212 Recombinant viruses coding for a glutamate decarboxylase (gad) activity |
| 03/07/2002 | CA2417261A1 Carotenoid production from a single carbon substrate |
| 03/06/2002 | EP1184464A2 Lycopen production method |
| 03/06/2002 | EP1184463A1 Method of detecting protein-protein interaction |
| 03/06/2002 | EP1184459A2 Manipulation of gene copy number in Bordetella |
| 03/06/2002 | EP1184398A1 Oligomer for media to entrap microorganism, oligomer-polymerized hydrous gel, and oligomer-polymerized hydrous gel entrapping microrganism |
| 03/06/2002 | EP1183385A1 Methods and materials for the synthesis of organic products |
| 03/06/2002 | EP1183383A1 Siv-based packaging-deficient vectors |
| 03/06/2002 | EP1183357A2 Vascular endothelial growth factor dimers |
| 03/06/2002 | EP1183345A2 Directed evolution of microorganisms |
| 03/06/2002 | EP1183338A1 Subtilase enzymes of the i-s1 and i-s2 sub-groups having at least one additional amino acid residue between positions 97 and 98 |
| 03/06/2002 | EP1183334A1 Trametes cingulata lignin depolymerase |
| 03/06/2002 | EP1183333A1 Methods of using rnase p reaction mechanisms of action |
| 03/06/2002 | EP1183328A2 Microcellular polymers as cell growth media and novel polymers |
| 03/06/2002 | EP1183269A1 Attenuated microorganisms for the treatment of infection |
| 03/06/2002 | EP1183268A1 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES |
| 03/06/2002 | EP1183265A1 Novel fabh enzyme, compositions capable of binding to said enzyme and methods of use thereof |
| 03/06/2002 | EP1029076A4 Screening for novel compounds which regulate biological interactions |
| 03/06/2002 | EP0726958B1 A new cephalosporin c acylase |
| 03/06/2002 | EP0710110B1 Antibodies of ring opened rapamycins |
| 03/06/2002 | CN1339107A Method of identifying N-terminal proBNP |
| 03/06/2002 | CN1339066A Alzheimer's disease secretase |
| 03/06/2002 | CN1339065A Method for preparing highly pure albumin solution |
| 03/06/2002 | CN1338940A Bidifobacterium in the treatment of inflammatory disease |
| 03/06/2002 | CN1080312C Rapamycin assay |
| 03/06/2002 | CN1080311C Peptide related to human programmed cell death and DNA cencoding it |
| 03/06/2002 | CN1080308C Antikanamycin gene originated from microbe |
| 03/06/2002 | CN1080307C Method and system for enhanced production of commercially important exoproteins in grampositive bacteria |
| 03/06/2002 | CN1080306C Adjusting and controlling factor for expression of nitrile solution deenzyme and gene thereof |
| 03/06/2002 | CN1080305C Preparation of hepatocellular cearcinoma oncogene |
| 03/06/2002 | CN1080304C Method for preparing modified L-protein for hepatitis B virus |
| 03/06/2002 | CN1080124C Pneumococcal polysaccharide conjugate vaccine |
| 03/05/2002 | US6352850 Chitinase and method for preparing the same |
| 03/05/2002 | US6352848 Nucleotide sequences of amino acid sequences |
| 03/05/2002 | US6352847 Ammonia elimination liquid reagent |
| 03/05/2002 | US6352846 A polypeptide; for transgenic plants with increased crop yields |
| 03/05/2002 | US6352839 Preparing virginiamycins from an engineered microorganisms, having the ability to prevent biosynthesis of the precursor antibiotic; the microorganism is cultured in the presence of a second precursor and the streptogramin analog is recovered |
| 03/05/2002 | US6352832 Anti-CCR2 antibodies and methods of use therefor |
| 03/05/2002 | CA2145290C Methods and compositions for controlling translation of hcv proteins |
| 03/05/2002 | CA2079463C Live vaccines |
| 03/05/2002 | CA1341345C Expression of foreign genes in drosophila cells |
| 02/28/2002 | WO2002016937A1 Method of screening remedy for heart failure |
| 02/28/2002 | WO2002016612A2 Genes and proteins, and their uses |
| 02/28/2002 | WO2002015680A1 Type iii allergic inflammation model animal |
| 02/28/2002 | WO2001060849A3 Cold-adapted equine influenza viruses |
| 02/28/2002 | WO2001025469A3 Method for preparing steroids modified by yeast fermentation |
| 02/28/2002 | US20020026036 Constructing cassette vector by inserting cDNA coding for heavy chain constant region of human antibody into expression vector for animal cell use, establishing cloning site, digesting cdna coding for heavy chain, inserting into vector |
| 02/28/2002 | US20020025567 Hydroxylation in presence of enzyme |
| 02/28/2002 | US20020025566 From dipeptides |
| 02/28/2002 | US20020025564 Method for producing basic amino acid |
| 02/28/2002 | US20020025559 Nucleotide sequences for use in the diagnosis and treatment of hypertension, heart, and kidney defects |
| 02/28/2002 | US20020025558 Human MAD proteins and uses thereof |
| 02/28/2002 | US20020025456 Process for producing electrical energy with the aid of a fuel cell |
| 02/28/2002 | US20020025328 As vaccines for immunization |
| 02/28/2002 | DE10036469A1 Ultraspiracle (USP)-Protein von Heliothis virescens Ultraspiracle (USP) protein of Heliothis virescens |
| 02/28/2002 | CA2420261A1 Genes and proteins, and their uses |
| 02/27/2002 | EP1182261A1 Method for producing basic amino acid |
| 02/27/2002 | EP1182257A1 Nucleic acids encoding dihydroflavonol 4-reductase with altered specificity and uses thereof |
| 02/27/2002 | EP1182253A2 Method for improving the thermostability of proteins |
| 02/27/2002 | EP1182213A1 Hybrid enzyme and use thereof |
| 02/27/2002 | EP1182212A2 Ultraspiracle USP-protetin of Heliothis virescens |
| 02/27/2002 | EP1181938A2 Rapamycin conjugates and antibodies |
| 02/27/2002 | EP1181386A1 Detection of viral stability |
| 02/27/2002 | EP1181384A1 A PROCESS FOR THE PREPARATION OF DERIVATIVES OF i RUSCUS ACULEATUS /i STEROID GLYCOSIDES |
| 02/27/2002 | EP1181378A1 Fusion proteins comprising a fragment of a chaperon polypeptide |
| 02/27/2002 | EP1181363A1 Recombinant human mannan-binding lectin |
| 02/27/2002 | EP1181319A1 Dr4 antibodies and uses thereof |
| 02/27/2002 | EP1181305A1 Methods of modulating activity of prokaryotic ribosomes |
| 02/27/2002 | EP1181038A2 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals |
| 02/27/2002 | EP1181037A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 02/27/2002 | EP1181027A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 02/27/2002 | EP1180999A2 Recombinant vaccine against botulinum neurotoxin |
| 02/27/2002 | EP1180937A1 Strains of bacteriophage useful for rescuing patients infected with vancomycin-resistant enterococcus faecium |
| 02/27/2002 | EP0931161B1 A process for the biotransformation of colchicinoid compounds into the corresponding 3-glycosyl derivatives |
| 02/27/2002 | EP0858509B1 Dna sequences encoding cmh-1, a cysteine protease involved in apoptosis |
| 02/27/2002 | EP0840792B1 (s)-hydroxynitrillyase from hevea brasiliensis |
| 02/27/2002 | EP0827548B1 Microbiological process for the preparation of (s,s)-n,n'-ethylenediaminedisuccinic acid |
| 02/27/2002 | EP0827545B1 Retroviral vectors |
| 02/27/2002 | EP0536330B1 Glyphosate tolerant plants |
| 02/27/2002 | CN1338002A Polysaccharides containing alpha-1,4-glucan chains and method for producing same |
| 02/27/2002 | CN1337998A Multi-enzyme product comprising glucoumylolytic, proteolytic and xylanolytic activities and process for preparing the same |
| 02/27/2002 | CN1337834A Power amplifier share in wireless communication system with transmitting diversity |
| 02/27/2002 | CN1337465A Gene sequency of specific dihydro-flavonol4-reducing enayme as code substrate and its use thereof |